Yu-Shan Wu
9PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|May 25, 2024
ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells.Chung-Pu Wu, Cheng-Yu Hung, Megumi Murakami
|Nov 25, 2023
Imperatorin Restores Chemosensitivity of Multidrug-Resistant Cancer Cells by Antagonizing ABCG2-Mediated Drug Transport.Chung-Pu Wu, Megumi Murakami, Yen-Ching Li
|Sep 28, 2023
Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells.Chung-Pu Wu, Yen-Ching Li, Megumi Murakami
|Apr 13, 2023
ABCB1 and ABCG2 Overexpression Mediates Resistance to the Phosphatidylinositol 3-Kinase Inhibitor HS-173 in Cancer Cell Lines.Chung-Pu Wu, Cheng-Yu Hung, Ya-Ju Hsieh
|Nov 11, 2022
Hydroxygenkwanin Improves the Efficacy of Cytotoxic Drugs in ABCG2-Overexpressing Multidrug-Resistant Cancer Cells.Yan-Qing Li, Megumi Murakami, Yang-Hui Huang
|May 14, 2022
P-glycoprotein Mediates Resistance to the Anaplastic Lymphoma Kinase Inhiitor Ensartinib in Cancer Cells.Chung-Pu Wu, Cheng-Yu Hung, Megumi Murakami
Pageof 2
